Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence-Guided Personalized Relaxation Intervention for Improving Quality of Life, Reducing Anxiety, and Enhancing Coping Strategies in Patients Undergoing Hemodialysis: A Mixed-Methods Randomized Controlled Trial

NCT07522944 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07522944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence-Guided Personalized Relaxation Intervention for Improving Quality of Life, Reducing Anxiety, and Enhancing Coping Strategies in Patients Undergoing Hemodialysis: A Mixed-Methods Randomized Controlled Trial
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2026
Completion date
August 30, 2026
Enrollment
125 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, maintenance hemodialysis, quality of life, relaxation therapy, renal insufficiency, chronic, stress, psychological